Lack of interleukin-1 signaling results in perturbed early vein graft wall adaptations
- PMID: 22853857
- PMCID: PMC3488356
- DOI: 10.1016/j.surg.2012.06.005
Lack of interleukin-1 signaling results in perturbed early vein graft wall adaptations
Abstract
Background: Vein grafts fail as the result of wall maladaptations to surgical injury and hemodynamic perturbations. Interleukin-1 signaling has emerged as an important mediator of the vascular response to trauma and hemodynamically induced vascular lesions. We therefore hypothesized that interleukin-1 signaling drives early vein graft wall adaptations.
Methods: Using interleukin-1 type I receptor knockout (IL-1RI(-/-)) and wild-type (B6129SF2/J) mice, we investigated morphologic changes 28 days after interposition isograft from donor inferior vena cava to recipient carotid artery, without (n = 19) or with (n = 13) outflow restriction. The impact of mouse strain on the response to vein arterialization also was evaluated between B6129SF2/J (n = 18) and C57BL/6J (n = 19) mice.
Results: No differences were observed in the traditional end points of intimal thickness and calculated luminal area, yet media+adventitia thickness of the vein graft wall of IL-1RI(-/-) mice was 44% to 52% less than wild-type mice, at the both proximal (P < .01, P < .01) and distal (P = .054, P < .01) portions of vein grafts, for both normal flow and low flow, respectively. Compared with the C57BL/6J strain, B6129SF2/J mice exhibited no difference in vein graft intimal thickness but 2-fold greater media+adventitia thickness (P < .01).
Conclusion: When lacking IL-1 signaling, the vein graft wall adapts differently compared with the injured artery, showing typical intima hyperplasia although attenuated media+adventitia thickening. B6129SF2/J mice exhibit more media+adventitia response than C57BL/6J mice. The inflammatory networks that underlie the vein response to arterialization hold many roles in the adaptation of the total wall; thus, the utility of anti-inflammatory approaches to extend the durability of vein grafts comes into question.
Copyright © 2013 Mosby, Inc. All rights reserved.
Figures


Similar articles
-
Perivascular innate immune events modulate early murine vein graft adaptations.J Vasc Surg. 2013 Feb;57(2):486-492.e2. doi: 10.1016/j.jvs.2012.07.007. Epub 2012 Nov 3. J Vasc Surg. 2013. PMID: 23127978 Free PMC article.
-
Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.J Vasc Surg. 2002 Oct;36(4):824-32. J Vasc Surg. 2002. PMID: 12368745
-
Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells.Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2277-83. doi: 10.1161/01.ATV.0000147766.68987.0d. Epub 2004 Oct 14. Arterioscler Thromb Vasc Biol. 2004. PMID: 15486311
-
Perivascular treatment with azathioprine reduces neointimal hyperplasia in experimental vein grafts.Heart Surg Forum. 2006;9(1):E515-7. doi: 10.1532/HSF98.20051168. Heart Surg Forum. 2006. PMID: 16401538
-
[Common carotid artery intima-media thickness: the role in evaluation of atherosclerosis progression].Neurol Neurochir Pol. 2001 Nov-Dec;35(6):1093-102. Neurol Neurochir Pol. 2001. PMID: 11987705 Review. Polish.
Cited by
-
Inflammation in Vein Graft Disease.Front Cardiovasc Med. 2018 Jan 24;5:3. doi: 10.3389/fcvm.2018.00003. eCollection 2018. Front Cardiovasc Med. 2018. PMID: 29417051 Free PMC article. Review.
-
Spatial Transcriptomic Profiling of Human Saphenous Vein Exposed to Ex Vivo Arterial Haemodynamics-Implications for Coronary Artery Bypass Graft Patency and Vein Graft Disease.Int J Mol Sci. 2024 Sep 26;25(19):10368. doi: 10.3390/ijms251910368. Int J Mol Sci. 2024. PMID: 39408698 Free PMC article.
-
Activation of Interleukin-1 Beta in Arterialized Vein Grafts and the Influence of the -511C/T IL-1β Gene Polymorphism.J Cardiovasc Dev Dis. 2019 Apr 30;6(2):20. doi: 10.3390/jcdd6020020. J Cardiovasc Dev Dis. 2019. PMID: 31052244 Free PMC article.
-
Distinct subsets of T cells and macrophages impact venous remodeling during arteriovenous fistula maturation.JVS Vasc Sci. 2020;1:207-218. doi: 10.1016/j.jvssci.2020.07.005. Epub 2020 Sep 1. JVS Vasc Sci. 2020. PMID: 33748787 Free PMC article.
-
Diet-induced obesity drives negative mouse vein graft wall remodeling.J Vasc Surg. 2014 Jun;59(6):1670-6. doi: 10.1016/j.jvs.2013.05.033. Epub 2013 Jul 19. J Vasc Surg. 2014. PMID: 23876511 Free PMC article.
References
-
- Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB, Jr., Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–54. - PubMed
-
- Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43:742–51. discussion 51. - PubMed
-
- Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190:300–9. - PubMed
-
- Wallitt EJ, Jevon M, Hornick PI. Therapeutics of vein graft intimal hyperplasia: 100 years on. Ann Thorac Surg. 2007;84:317–23. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical